Met
The MET family of receptor tyrosine kinases contains MET, the receptor for hepatocyte growth factor (HGF, scatter factor), and RON (MST1R), the receptor for macrophage-stimulating protein. Both receptors have a characteristic extracellular sema domain, found also in plexins and semaphorins, plus a PSI domain and four immunoglobulin-like repeats. Ligand-induced dimerization triggers kinase activation and a program of invasive growth involving scattering, proliferation, survival, angiogenesis and morphogenesis, essential for embryogenesis, liver regeneration and wound healing. MET is pathologically activated by exon 14 skipping, amplification and activating mutations in lung, gastric, liver and kidney cancers, and by HGF overexpression. MET inhibitors such as cabozantinib, capmatinib and tepotinib are now approved anticancer agents.
-
Met Recombinant Proteins (36)
HGFR Protein, Human (Active, sf9, His-GST)
0 Images
Art. -Nr.: HY-P72938
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, ΔD963-E1009, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705789
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- Species:
- Source:
HGFR Protein, Human (Active, D1228N, sf9, His-GST)
0 Images
Art. -Nr.: HY-P72938A
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
RON/MSPR Protein, Human (Active, sf9, GST)
0 Images
Art. -Nr.: HY-P705604
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MST1R; S13 Avian Erythroblastosis Oncogene Homolog; Prev. PTK8; C-Met-Related Tyrosine Kinase; Prev. RON; MSP Receptor; Prev. SEA; S13 Erythroblastosis (Avian) Oncogene Homolog; CDw136; S13 Erythroblastosis Oncogene Homolog; Macrophage-Stimulating Protein
- Species:
- Source:
HGFR Protein, Human (Active, M1250I, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705764
Reinheit: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, T1173I, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705765
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, K1244R, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705766
Reinheit: ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, L1195V, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705767
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, M1250T, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705768
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, T992I, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705769
Reinheit: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, V1092I, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705770
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, Y1230A, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705771
Reinheit: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, Y1230H, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705772
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, F1200I, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705773
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, L1195F, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705774
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, R970C, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705775
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, D1228A, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705776
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, D1228G, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705777
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, D1228H, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705778
Reinheit: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
HGFR Protein, Human (Active, D1228V, sf9, His-GST)
0 Images
Art. -Nr.: HY-P705779
Reinheit: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- Species:
- Source:
- 1
- 2
Recombinant Protein Expression Service
- Codon Optimization
- Gene Synthesis
- Construction of Expression Vector
- Strain Screening
- Protein Expression
- Purification & QC
- Protein Delivery
- 1
- 2
Capetin (28-54), human
0 Images
Synonyms: Serpin B6; Cytoplasmic Antiproteinase; cap; Peptidase Inhibitor
- Formel: Human
- Molecular Weight: Sf9 insect cells
The EpCAM/TROP1 protein serves as an important homogeneous interacting molecule that promotes direct contact between intestinal epithelial cells (IEC) and intraepithelial lymphocytes (IEL) in the mucosal epithelium. This feature helps establish an immune barrier against mucosal infections. EpCAM/TROP1 Protein, Human (His-SUMO) is the recombinant human-derived EpCAM/TROP1 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.
